Hallucinogens recruit specific cortical 5-HT(2A) receptor-mediated signaling pathways to affect behavior - PubMed (original) (raw)
. 2007 Feb 1;53(3):439-52.
doi: 10.1016/j.neuron.2007.01.008.
Noelia V Weisstaub, Mingming Zhou, Pokman Chan, Lidija Ivic, Rosalind Ang, Alena Lira, Maria Bradley-Moore, Yongchao Ge, Qiang Zhou, Stuart C Sealfon, Jay A Gingrich
Affiliations
- PMID: 17270739
- DOI: 10.1016/j.neuron.2007.01.008
Free article
Hallucinogens recruit specific cortical 5-HT(2A) receptor-mediated signaling pathways to affect behavior
Javier González-Maeso et al. Neuron. 2007.
Free article
Abstract
Hallucinogens, including mescaline, psilocybin, and lysergic acid diethylamide (LSD), profoundly affect perception, cognition, and mood. All known drugs of this class are 5-HT(2A) receptor (2AR) agonists, yet closely related 2AR agonists such as lisuride lack comparable psychoactive properties. Why only certain 2AR agonists are hallucinogens and which neural circuits mediate their effects are poorly understood. By genetically expressing 2AR only in cortex, we show that 2AR-regulated pathways on cortical neurons are sufficient to mediate the signaling pattern and behavioral response to hallucinogens. Hallucinogenic and nonhallucinogenic 2AR agonists both regulate signaling in the same 2AR-expressing cortical neurons. However, the signaling and behavioral responses to the hallucinogens are distinct. While lisuride and LSD both act at 2AR expressed by cortex neurons to regulate phospholipase C, LSD responses also involve pertussis toxin-sensitive heterotrimeric G(i/o) proteins and Src. These studies identify the long-elusive neural and signaling mechanisms responsible for the unique effects of hallucinogens.
Similar articles
- Quantitative phosphoproteomics unravels biased phosphorylation of serotonin 2A receptor at Ser280 by hallucinogenic versus nonhallucinogenic agonists.
Karaki S, Becamel C, Murat S, Mannoury la Cour C, Millan MJ, Prézeau L, Bockaert J, Marin P, Vandermoere F. Karaki S, et al. Mol Cell Proteomics. 2014 May;13(5):1273-85. doi: 10.1074/mcp.M113.036558. Epub 2014 Mar 17. Mol Cell Proteomics. 2014. PMID: 24637012 Free PMC article. - LSD but not lisuride disrupts prepulse inhibition in rats by activating the 5-HT(2A) receptor.
Halberstadt AL, Geyer MA. Halberstadt AL, et al. Psychopharmacology (Berl). 2010 Feb;208(2):179-89. doi: 10.1007/s00213-009-1718-x. Epub 2009 Nov 25. Psychopharmacology (Berl). 2010. PMID: 19937319 Free PMC article. - Serotonergic and dopaminergic distinctions in the behavioral pharmacology of (±)-1-(2,5-dimethoxy-4-iodophenyl)-2-aminopropane (DOI) and lysergic acid diethylamide (LSD).
Schindler EA, Dave KD, Smolock EM, Aloyo VJ, Harvey JA. Schindler EA, et al. Pharmacol Biochem Behav. 2012 Mar;101(1):69-76. doi: 10.1016/j.pbb.2011.12.002. Epub 2011 Dec 14. Pharmacol Biochem Behav. 2012. PMID: 22197710 Free PMC article. - Hallucinogens and Serotonin 5-HT2A Receptor-Mediated Signaling Pathways.
López-Giménez JF, González-Maeso J. López-Giménez JF, et al. Curr Top Behav Neurosci. 2018;36:45-73. doi: 10.1007/7854_2017_478. Curr Top Behav Neurosci. 2018. PMID: 28677096 Free PMC article. Review. - Serotonin and hallucinogens.
Aghajanian GK, Marek GJ. Aghajanian GK, et al. Neuropsychopharmacology. 1999 Aug;21(2 Suppl):16S-23S. doi: 10.1016/S0893-133X(98)00135-3. Neuropsychopharmacology. 1999. PMID: 10432484 Review.
Cited by
- Psilocybin and Eugenol Reduce Inflammation in Human 3D EpiIntestinal Tissue.
Robinson GI, Li D, Wang B, Rahman T, Gerasymchuk M, Hudson D, Kovalchuk O, Kovalchuk I. Robinson GI, et al. Life (Basel). 2023 Dec 15;13(12):2345. doi: 10.3390/life13122345. Life (Basel). 2023. PMID: 38137946 Free PMC article. - Mechanisms of SSRI Therapy and Discontinuation.
Sharp T, Collins H. Sharp T, et al. Curr Top Behav Neurosci. 2024;66:21-47. doi: 10.1007/7854_2023_452. Curr Top Behav Neurosci. 2024. PMID: 37955823 Review. - Psychedelics Recruit Multiple Cellular Types and Produce Complex Transcriptional Responses Within the Brain.
Martin DA, Nichols CD. Martin DA, et al. EBioMedicine. 2016 Sep;11:262-277. doi: 10.1016/j.ebiom.2016.08.049. Epub 2016 Sep 3. EBioMedicine. 2016. PMID: 27649637 Free PMC article. - Molecular mechanisms of serotonergic action of the HIV-1 antiretroviral efavirenz.
Dalwadi DA, Kim S, Amdani SM, Chen Z, Huang RQ, Schetz JA. Dalwadi DA, et al. Pharmacol Res. 2016 Aug;110:10-24. doi: 10.1016/j.phrs.2016.04.028. Epub 2016 May 6. Pharmacol Res. 2016. PMID: 27157251 Free PMC article. - The Psychedelic Future of Post-Traumatic Stress Disorder Treatment.
Zaretsky TG, Jagodnik KM, Barsic R, Antonio JH, Bonanno PA, MacLeod C, Pierce C, Carney H, Morrison MT, Saylor C, Danias G, Lepow L, Yehuda R. Zaretsky TG, et al. Curr Neuropharmacol. 2024;22(4):636-735. doi: 10.2174/1570159X22666231027111147. Curr Neuropharmacol. 2024. PMID: 38284341 Free PMC article. Review.
Publication types
MeSH terms
Substances
Grants and funding
- K08 MH01711/MH/NIMH NIH HHS/United States
- T32 DA007135/DA/NIDA NIH HHS/United States
- P01 DA12923/DA/NIDA NIH HHS/United States
- T32 DA07135/DA/NIDA NIH HHS/United States
- P01 DA012923/DA/NIDA NIH HHS/United States
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases
Miscellaneous